LLY Related New Coverage
-
Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza
-
CLSA Starts Eli Lilly (LLY) at Sell
-
Citi Starts Eli Lilly (LLY) at Buy
-
BMO Capital Starts Eli Lilly (LLY) at Market Perform
-
ISI Group Starts Eli Lilly (LLY) at Hold
-
MKM Partners Starts Eli Lilly (LLY) at Sell
-
Soleil Starts Eli Lilly (LLY) at Sell, $28 Price Target
-
Jefferies & Co Initiates Coverage on Big Pharma Stocks LLY & BMY
-
Merriman Curhan Ford Initiates Coverage on Amylin Pharmaceuticals (AMLN) with a Buy
-
UBS Modestly Positive On US Large-Cap Pharma (MRK, PFE, BMY, LLY)
-
Wells Fargo Starts Eli Lilly (LLY) at Market Perform
-
Morgan Stanley Initiates Coverage on Eli Lilly & Co (LLY) with an Underweight
-
Deutsche Bank Initiates Coverage on Covance (CVD) with a Buy; 'Strategically' Best Suited to Gain Share
-
Auriga Initiates Coverage on United Therapeutics (UTHR) with a Buy
-
Goldman Sachs Starts Coverage On Drug Makers; WYE & BMY at Buy, PFE at Sell, LLY & MRK at Neutral
-
Citi Initiates Coverage on Eli Lilly (LLY) with a Neutral
-
J.P. Morgan Initiates Coverage on Major Drug Manufacturers - BMY, LLY & WYE
-
BMO Capital Initiates Coverage on Eli Lilly (LLY)
-
Banc of America Starts Coverage on a Number of Pharma Stocks
-
Bear Stearns Reinitiated LLY
Back to LLY Stock Lookup
